Citadel Advisors Llc

13F Holdings History for Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 (AARD)

Symbol: AARD on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001
Latest Disclosed Ownership: 1.19M shares
Security Ownership: 5.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Kenneth Griffin ownership in Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 (AARD)

2025-02-24 - Kenneth Griffin has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.19M shares of Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 (AARD). This represents 5.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Kenneth Griffin	5.6%		$8.52M	1.19M			$7.14	13G	2/14/2025	24 Feb 2025 17:55:38

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$18.1M	1.36M	+76,151	+5.93%	$13.29	Q3 2025
6/30/2025	0.02%	+0%	$17.4M	1.28M	+9,648	+0.76%	$13.52	Q2 2025
3/31/2025	0.01%	+0.01%	$9.44M	1.27M	+1,274,084	NEW	$7.41	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.